PS2 - Hot Topic: Developing evidence during a pandemic – Ethical research, reliable science, safe practice
Sorry, Access to this content is only open to registered participants.
If you are not registered yet, click HERE for more information how to register for FIP2020.
If you are not registered yet, click HERE for more information how to register for FIP2020.
FIP Programme Committee
Chairs
Michael Ward, University of South Australia, Australia and Hiroshi Suzuki, The University of Tokyo Hospital, JapanIntroduction
Session needs registration (to register click HERE)
On the day of the session, you can access the session with your registration details.
Programme
- Developing the epidemiology of COVID-19 – getting to know the virus, infectiousness, mutations, transmissibility, and control of a pandemic
Koh Okamoto, University of Tokyo Hospital, Japan - Developing a vaccine – where are we now and how do we meet the challenges of public demand?
Natalie Prow, UniSA Cancer Research Institute, Australia - Developing new treatments, challenges, pitfalls and unintended consequences – from re-purposing to the search for novel therapeutics
Craig Rayner, Certara, Australia - Developing evidence for patient groups at risk (identifying risk factors, educating patients and preventing the spread of misinformation)
Ricardo Mexia, Associação Nacional dos Médicos de Saúde Pública, Portugal
